|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/17 | |
| C12N 5/0783 |
| (11) | Number of the document | 3105317 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15706399.1 |
| Date of filing the European patent application | 2015-02-13 | |
| (97) | Date of publication of the European application | 2016-12-21 |
| (45) | Date of publication and mention of the grant of the patent | 2018-09-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/053162 |
| Date | 2015-02-13 |
| (87) | Number | WO 2015/121454 |
| Date | 2015-08-20 |
| (30) | Number | Date | Country code |
| 201470076 | 2014-02-14 | DK |
| (72) |
DUCHATEAU, Philippe, FR
POIROT, Laurent, FR
|
| (73) |
Cellectis,
8, rue de la Croix Jarry, 75013 Paris,
FR
|
| (54) | CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BOTH ON IMMUNE CELLS AND PATHOLOGICAL CELLS |
| CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING ANTIGEN PRESENT BOTH ON IMMUNE CELLS AND PATHOLOGICAL CELLS |